How can we effectively identify and report clinical research misconduct?
Utilizing interim Phase II results to streamline Phase III development: what does the future hold?
An evaluation of recruitment methods utilized for a clinical trial with periodontal and diabetes enrollment criteria: the Diabetes and Periodontal Therapy Trial
Changing the paradigm: circulating tumor DNA as a ‘liquid biopsy’ for clinical biomarker assessments
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Therapeutic targeting of tumor angiogenesis: how far have we come?
The phosphatidyl-inositol 3-kinase/Akt/mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Overview on clinical trials in Waldenstrom's macroglobulinemia